ADGSOM1 & ADGMIN1  
       
  LAUNCH OF THE 50TH ANNIVERSARY CELEBRATION OF RUKUN NEGARA  
       
  KL SUMMIT 2019  
       
  HAWANA 2018  
       
  AES 2016  
       

 
 
 

November 27, 2024 -Wednesday

 
  UNIVERSAL THERAPEUTICS DIAGNOSTICS SDN BHD RECEIVES FORMAL APPROVAL FROM MEDICAL DEVICE AUTHORITY (MDA), MALAYSIA OUR IN-HOUSE MANUFACTURING LICENCE

Thursday 03/11/2022



KUALA LUMPUR, Nov 3 (Bernama) -- Universal Therapeutics Diagnostics Sdn Bhd (“UTD”) receives the official nod from it’s competent and governing authority Medical Device Authority (MDA, Ministry of Health), Malaysia to commence her In- Vitro Diagnostics (“IVD”) production in its own facility.
 

Proudly “In-house” and “Made in Malaysia”, the plant boasts a menu of IVDs for medical practitioners and home users. UTD’s current focus will be pregnancy, infectious diseases, drug, dengue, and malaria IVDs.
 
Apart from serving the Malaysian domestic market, UTD also has orders from other countries to provide OEM and ODM services to meet their needs.
 
Dato’ Sri Samuel Chai, Chief Executive Officer of UTD shares, “The driver behind this facility is to provide Accurate, Precise and Simple solutions. Covid-19 has shared an experience with us to never take for granted accurate and simple testing at the comfort of our own space”.
 
As part of the roadmap to improve and to stay ahead of the growing needs in the market and her product offering, the facility is developing it’s own research and development laboratory.

About Universal Therapeutics Diagnostics Sdn Bhd
 
Established in 2021, UTD’s core focus is in the manufacturing and distribution of In-Vitro Diagnostics (IVD). UTD has her own manufacturing facility in Malaysia focused on pregnancy, infectious diseases, drug, dengue, and malaria IVDs. UTD also provides OEM and ODM services. UTD has been certified as a distributor with GDPMD by SGS and as a manufacturer by Medical Device Authority (MDA, Ministry of Health Malaysia).
 
SOURCE: Universal Therapeutics Sdn. Bhd.
 
FOR MORE INFORMATION, PLEASE CONTACT:
Name: Samuel David CHAI
Chief Commercial Officer
Tel: +60 3 9213 0318
Email: GroupPR@Universal-Therapeutics.com
Website: www.Universal-Therapeutics.com

 
--BERNAMA

 
 
 

Copyright © 2024 MREM . All rights reserved.